General Approach to Conducting Clinical Studies

BOX 6-1 Questions That Should Be Answered When Conducting Clinical Studies 

MANUFACTURER/REGULATORY AGENCY DETERMINES INGREDIENT IS SAFE 

Assess symptoms and adverse laboratory indicators in the following  

FIGURE 6-1 Proposed clinical assessment algorithm. [ a decision point, = an action, sidebar = an elaboration of recommendation or statement 

PROPOSED LEVELS OF CLINICAL ASSESSMENT OF MAJOR SYSTEMS 

---